You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 10, October 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (67)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Public Health
 •Substance Abuse/ Alcoholism
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs

A National Drug Abuse Treatment Clinical Trials Network Study

Nancy M. Petry, PhD; Jessica M. Peirce, PhD; Maxine L. Stitzer, PhD; Jack Blaine, MD; John M. Roll, PhD; Allan Cohen, MA, MFT; Jeanne Obert, MS; Therese Killeen, PhD; Michael E. Saladin, PhD; Mark Cowell, BA; Kimberly C. Kirby, PhD; Robert Sterling, PhD; Charlotte Royer-Malvestuto, MEd; John Hamilton, MFT; Robert E. Booth, PhD; Marilyn Macdonald, BA; Marc Liebert, MA; Linda Rader, BA; Raynetta Burns, MA; Joan DiMaria, MSN; Marc Copersino, PhD; Patricia Quinn Stabile, MSW; Ken Kolodner, ScD; Rui Li, MS

Arch Gen Psychiatry. 2005;62:1148-1156.

Context  Contingency management interventions that provide tangible incentives based on objective indicators of drug abstinence are efficacious in improving outcomes in substance abusers, but these treatments have rarely been implemented in community-based settings.

Objective  To evaluate the efficacy of an abstinence-based contingency management intervention as an addition to usual care in community treatment settings.

Design  Random assignment to usual care or usual care plus abstinence-based incentives for 12 weeks.

Setting  Eight community-based outpatient psychosocial drug abuse treatment programs.

Participants  A total of 415 cocaine or methamphetamine users beginning outpatient substance abuse treatment.

Intervention  All participants received standard care, and those assigned to the abstinence-based incentive condition also earned chances to win prizes for submitting substance-free urine samples; the chances of winning prizes increased with continuous time abstinent.

Main Outcome Measures  Retention, counseling attendance, total number of substance-free samples provided, percentage of stimulant- and alcohol-free samples submitted, and longest duration of confirmed stimulant abstinence.

Results  Participants assigned to the abstinence-based incentive condition remained in treatment for a mean ± SD of 8.0 ± 4.2 weeks and attended a mean ± SD of 19.2 ± 16.8 counseling sessions compared with 6.9 ± 4.4 weeks and 15.7 ± 14.4 sessions for those assigned to the usual care condition (P<.02 for all). Participants in the abstinence-based incentive condition also submitted significantly more stimulant- and alcohol-free samples (P<.001). The abstinence-based incentive group was significantly more likely to achieve 4, 8, and 12 weeks of continuous abstinence than the control group, with odds ratios of 2.5, 2.7, and 4.5, respectively. However, the percentage of positive samples submitted was low overall and did not differ between conditions.

Conclusion  The abstinence-based incentive procedure, which provided a mean of $203 in prizes per participant, was efficacious in improving retention and associated abstinence outcomes.


Author Affiliations: Department of Psychiatry, University of Connecticut School of Medicine, Farmington (Dr Petry); Mid-Atlantic Node, Johns Hopkins University School of Medicine, Baltimore, Md (Drs Peirce, Stitzer, and Kolodner and Mss Quinn Stabile and Li); Biopharmaceutical Research Consultants Inc, Ann Arbor, Mich (Dr Blaine); Washington State University, Tacoma (Dr Roll); Pacific Node, University of California at Los Angeles (Mr Cohen and Ms Obert); South Carolina Node, Medical University of South Carolina, Charleston (Drs Killeen and Saladin and Mr Cowell); Delaware Valley Node, University of Pennsylvania and Treatment Research Institute, Philadelphia (Drs Kirby and Sterling and Ms Royer-Malvestuto); New England Node, Yale University, New Haven, Conn (Mr Hamilton); Rocky Mountain Node, University of Colorado, Denver (Dr Booth; Mss Macdonald, Rader, Burns, and DiMaria; and Mr Liebert); and National Institute on Drug Abuse Intramural Research Program, Baltimore (Dr Copersino).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reinforcing Abstinence and Treatment Participation Among Offenders in a Drug Diversion Program: Are Vouchers Effective?
Hall et al.
Criminal Justice and Behavior 2009;36:935-953.
ABSTRACT  

Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
McCarty et al.
Psychiatr. Serv. 2007;58:181-190.
ABSTRACT | FULL TEXT  

Extending Contingency Management to the Treatment of Methamphetamine Use Disorders
Higgins
Am. J. Psychiatry 2006;163:1870-1872.
FULL TEXT  

Contingency management treatments
Petry
Br. J. Psychiatry 2006;189:97-98.
ABSTRACT | FULL TEXT  

Abstinence incentives improve stimulant abusers' compliance with community-based psychosocial treatments.
Sorensen
Evid. Based Ment. Health 2006;9:55-55.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.